KPC Pharmaceuticals is a Chinese pharmaceutical company that manufactures and develops pharmaceutical products with a focus on international markets.

KPC Pharmaceuticals

KPC Pharmaceuticals, Inc 昆药集团股份有限公司 | 214 followers on LinkedIn. KPC is a pharmaceutical company which focused on innovative natural botanical drugs. | KPC Pharmaceuticals, Inc (hereinafter be abbreviated as ‘KPC’, 600422 SH) was established in March 1951 and floated on the Shanghai Stock Exchange in December 2000. With its considerable professional experience in pharmaceutical industry, the company is listed as one of the new key national high-tech companies and one of the Top 100 companies in the Chinese medical industry. The company’s brands such as Luotai®, Tianxuanqing®, Artemedine®, Artem® and Arco® currently enjoy a good reputation both at home and abroad.

Deputy General Manager at Overseas Division@KPC/Anti-malarial/DUO-COTECXIN

Eric Guo

昆药集团股份有限公司 - 临床研究中心主任

高铎Duo GAO

KPC PHARMACEUTICAl - 商务总监

丁志强

Asssociate Director of Business Development at KPC Pharmaceuticals, Inc.

Jungang Wang

KPC Pharmaceuticals, Inc 昆药集团股份有限公司

Viewport Meta

IPhone / Mobile Compatible

SSL by Default

Apple Mobile Web Clips Icon

Mobile Non Scaleable Content

nginx

Apache

ASP.NET

Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.

Asia Pharmaceutical Companies

Asia-Pacific (APAC) Biotechnology Public Companies

Biotechnology Companies With More Than $10M in Revenue

Health Care Public Companies With Fewer Than 1000 Employees

KPC is a pharmaceutical company that engages in the manufacture of pharmaceuticals. Tablets, fluids, ointments, and injectables are among their offerings. Its goal is to improve people's lives by enabling them to achieve more, feel better, and live longer. They have technological machinery, skilled and motivated individuals, and management systems that can handle both quantity and quality of work. They are looking for new ways to improve their performance, raise their integrity to a level of excellence, implement their initiatives, and achieve their goals.

Kunming

Yunnan

China

Asia

KPC mandates electronic attendance tracking for subsidiaries

Kuwait: KPC awards $3.1mln cybersecurity tender

KPC CEO: Dedicated to enhancing leadership skills in the oil sector

KPC invites 18 companies for LNG filling tender

KPC expands ties at APEC ’24

QatarEnergy, KPC sign 15-year agreement to supply up to 3 MTPA of LNG to Kuwait

KPC CEO advocates for full Kuwaitization of oil sector

Drilling at Durra gas field to start this year: KPC

Kuwait crude oil edge 78 higher Wed. to USD 85.01 pb – KPC

Kuwait oil up by 86 cents Wed. to USD 86.39 pb – KPC

A range of products derived from Artemisia, used primarily for their antimalarial properties.

Products based on Panax Notoginseng, known for their use in cardiovascular health and blood circulation.

A series of products utilizing Gastrodia, often used for neurological health and treating headaches.

A collection of unique botanical drugs developed from various plant resources.

High-quality traditional Chinese medicine products.

A series of prescription drugs recognized globally.

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.

KPC Pharmaceuticals, Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 8:44 PM	da50870e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 8:44 PM	da6efac8
crunchbase trigger	general	Nov 17, 2024 8:44 PM	7e6a1742
crunchbase profile	general	Nov 17, 2024 9:05 PM	ab221bd7
li profile	general	Nov 17, 2024 8:44 PM	66691c58
translate crunchbase fundingrounds	general	Nov 17, 2024 9:30 PM	006fb093
peers	general	Nov 17, 2024 8:44 PM	fb6ef30b
news basic	general	Nov 17, 2024 8:44 PM	57d639d9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

6004

CN:COM:KPC

KPC Pharmaceuticals

Last Close

15.08

22/11 07:00

Market Cap

12.73B

Beta: -

Volume Today

14.99M

Avg: -